Recombinant IL6 (Siltuximab Biosimilar) antibody

Catalog No. ABIN7487790

This Mammalian Cells Monoclonal antibody specifically detects IL6 (Siltuximab Biosimilar) in ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant IL6 (Siltuximab Biosimilar) antibody (ABIN7487790)

Target: IL6 (Siltuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IL6 (Siltuximab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-IL6 (Siltuximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Siltuximab Biosimilar - Anti-IL6 mAb

Characteristics: Antibody Type: IgG1Kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: 4 °C,-20 °C

Storage Comment: 4°C for short term, -20°C for long term

Target Details for IL6 (Siltuximab Biosimilar)

Target: IL6 (Siltuximab Biosimilar)

Target Type: Biosimilar

Background: Siltuximab
The Siltuximab antibody is a chimeric mouse/human therapeutic antibody obtained from mouse hybridoma. It is one of several IgG1 antibodies known to bind the human interleukin 6 (IL-6) molecule, a soluble glycoprotein with a key role in pro-inflammatory responses. IL-6 is one of the main proinflammatory cytokines overexpressed in multiple pathologies (e.g. viral infections, rheumatoid arthritis, MCD, etc.).